Measurement of Proteasome Activity in Peripheral Blood Mononuclear Cells as an Indicator of Susceptibility to Bortezomib-Induced Severe Neurological Adverse Events in Patients with Multiple Myeloma

Yukiko Cho(Ibaraki Prefectural Central Hospital), Daisuke Kudo(Barrow Neurological Institute), Keiji Tanaka(RIKEN Center for Brain Science), Mitsuo Hori(Ibaraki Prefectural Central Hospital), Ikuyo Ota(National Hospital Organization Mito Medical Center), Takuya Komeno(National Hospital Organization Mito Medical Center), Fumie Fujisawa, Yukitaka Katsura(National Hospital Organization Mito Medical Center), Masaharu Kamoshita(Tsuchiura Kyodo General Hospital), Katsuhiro Sasaki(Kyoto University), Seiichi Shimizu(Tsuchiura Kyodo General Hospital), Hiroshi Kojima(Ibaraki Prefectural Central Hospital), Yasushi Okoshi(Ibaraki Prefectural Central Hospital), Harumi Y. Mukai, Atsushi Shinagawa(Hitachi General Hospital), Chikashi Yoshida(National Hospital Organization Mito Medical Center)
Acta Haematologica
January 1, 2015
Cited by 1


Related Papers